[18F]PSMA-1007 had been synthesized according to Cardinale et al. (18 (link)). The mean injected activity of [18F]PSMA-1007 was 299 MBq (min–max: 249–370 MBq). Patients underwent a whole-body PET scan starting 2 h after injection. Scans were performed with a 16-slice Gemini TF big bore in one patient and a Vereos PET/CT scanner in nine patients (all Philips Healthcare, USA). A phantom study was performed and comparable SUV values were obtained in both systems (19 (link)). Both scanners fulfilled the requirements indicated in the European Association of Nuclear Medicine (EANM) imaging guidelines and obtained EANM Research Ltd (EARL). accreditation during acquisition. At the time of the PET scan, either a contrast-enhanced or native diagnostic CT scan (120 kVp, 100–400 mAs, dose modulation) was performed for attenuation correction (depending on previous CT scans and contraindications). Please see (19 (link)) for details about reconstruction methods. All systems resulted in a PET image with a voxel size of 2 × 2 × 2 mm3. The uptake of [18F]PSMA-1007 was quantified in terms of standardized uptake values (SUV) normalized body weight.
Free full text: Click here